[1]
O. Bozkurt, S. Tarik Firat, E. Dogan, R. Cosar, M. Inanc, and M. Ozkan, “The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy ”, Ann Med Res , vol. 26, no. 10, pp. 2098–2104, May 2021, Accessed: Sep. 16, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/1820